Conclusion: Preclinical Horizons in Incretin and Repair Assays While empirical anecdotal feedback in private forums frequently highlights the efficiency of BPC-157 in tissue repair models, human clinical testing remains strictly outside current scientific parameters
*Correspondence: Amin Talebi Bezmin Abadi, [email protected] This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
[DOI] [PMC free article] [PubMed] [Google Scholar] Zhang Y
So, its still like, I hate to say, a dark market kind of thing or black market kind of thing, but thats kind of like what it seems like right now
Conclusion The recognition of BBB dysfunction as a common feature in multiple neurodegenerative disorders has underscored the importance of maintaining healthy blood vessels for optimal neural function